These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12145256)

  • 1. Metabolic control and adherence to american diabetes association practice guidelines in a pharmacist-managed diabetes clinic.
    Nowak SN; Singh R; Clarke A; Campbell E; Jaber LA
    Diabetes Care; 2002 Aug; 25(8):1479. PubMed ID: 12145256
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic.
    Irons BK; Lenz RJ; Anderson SL; Wharton BL; Habeger B; Anderson HG
    Pharmacotherapy; 2002 Oct; 22(10):1294-300. PubMed ID: 12389879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetics' usage in type 2 diabetes mellitus: Are prescribing guidelines adhered to? A single centre study.
    Khalil V; Sajan C; Tsai T; Ma D
    Diabetes Metab Syndr; 2018 Sep; 12(5):635-641. PubMed ID: 29666033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing treatment guidelines for type 2 diabetes in primary care.
    Brunton S
    Postgrad Med; 2009 Mar; 121(2):125-38. PubMed ID: 19332971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocols for the treatment of essential hypertension and type II diabetes mellitus by pharmacists in ambulatory care clinics.
    Tiggelaar JM
    Drug Intell Clin Pharm; 1987 Jun; 21(6):521-9. PubMed ID: 3608799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
    Winkelmayer WC; Stedman MR; Pogantsch M; Wieninger P; Bucsics A; Asslaber M; Bauer R; Burkhardt T; Schautzer A; Brookhart MA;
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):57-65. PubMed ID: 21182153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
    Kirby M
    Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care.
    Schultz JL; Horner KE; McDanel DL; Miller ML; Beranek RL; Jacobsen RB; Sly NJ; Miller AC; Mascardo LA
    J Pharm Pract; 2018 Jun; 31(3):268-271. PubMed ID: 28532224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The goal blood pressure in type 2 diabetes: do we have an ACCORD?
    Crouch MA
    Consult Pharm; 2010 Oct; 25(10):686, 688. PubMed ID: 21030359
    [No Abstract]   [Full Text] [Related]  

  • 11. Approaches to treatment 1: How is type 2 diabetes actually treated?
    Bloomgarden ZT
    J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
    [No Abstract]   [Full Text] [Related]  

  • 12. Membership in a diabetes-care network and adherence to clinical practice guidelines for treating type 2 diabetes among general practitioners: A four-year follow-up.
    Casanova L; Bocquier A; Cortaredona S; Nauleau S; Sauze L; Sciortino V; Villani P; Verger P
    Prim Care Diabetes; 2016 Oct; 10(5):342-51. PubMed ID: 27483997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.
    LaMarr B; Valdez C; Driscoll K; Ryan M
    Am J Health Syst Pharm; 2010 Feb; 67(4):290-4. PubMed ID: 20133534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review.
    Horning KK; Hoehns JD; Doucette WR
    J Manag Care Pharm; 2007; 13(1):28-36. PubMed ID: 17269834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing special populations among patients with type 2 diabetes mellitus.
    Marquess JG
    Pharmacotherapy; 2011 Dec; 31(12 Suppl):65S-72S. PubMed ID: 22122224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review.
    Wang Y; Yeo QQ; Ko Y
    Diabet Med; 2016 Apr; 33(4):421-7. PubMed ID: 26433008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus.
    Liday C
    Pharmacotherapy; 2011 Dec; 31(12 Suppl):37S-43S. PubMed ID: 22122221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Falconnier Bendik C; Donath MY
    Ther Umsch; 2016; 73(6):340-8. PubMed ID: 27646432
    [No Abstract]   [Full Text] [Related]  

  • 19. Do interventions by allied health professionals discussing adherence to insulin improve this adherence?
    Doggrell SA; Chan V
    Diabetes Res Clin Pract; 2014 Jun; 104(3):e61-3. PubMed ID: 24768512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.